Characteristics | Women n = 1,030 (55.3%) | Difference* (95% CI) | Men n = 831 (44.7%) | Difference* (95% CI) | p-value interaction term gender | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Total n = 1,030 | LTE n = 154 (15.0%) | No LTE n = 876 (85.0%) | p-value | Total n = 831 | LTE n = 155 (18.7%) | No LTE n = 676 (81.3%) | p-value | ||||
Mean age in years (SD) | 52.5 (22.0) | 66.7 (18.7) | 50.0 (21.6) | < 0.001§ | 16.8 (13.1 to 20.4) | 54.4 (20.9) | 62.8 (17.7) | 52.5 (21.1) | < 0.001§ | 10.4 (6.8–13.9) | 0.061|| |
Call characteristics | |||||||||||
 Call duration in min:sec (SD) (n = 1,843)** | 11:53 (39:38) | 13:54 (51:25) | 11:32 (37:17) | 0.498§ | 2:21 (−4:28 to 9:11) | 14:02 (1:03:02) | 10:31 (5:26) | 14:56 (1:10:23) | 0.438§ | −4:24 (−15:33 to 6:44) | 0.482|| |
 Calling at night (noon-8 AM) | 170 (16.5%) | 37 (24.0%) | 133 (15.2%) | 0.006‡ | 8.8 (1.6 to 16.0) | 181 (21.8%) | 29 (18.7%) | 152 (22.5%) | 0.300‡ | 3.8 (−3.1 to 10.7) | 0.009|| |
 Someone else called on behalf of patient (n = 1,857)** | 485 (47.2%) | 108 (70.6%) | 377 (43.1%) | < 0.001‡ | 27.5 (19.6 to 35.4) | 462 (55.7%) | 121 (78.1%) | 341 (50.5%) | < 0.001‡ | 27.6 (20.1 to 35.1) | 0.732|| |
 GP participated in triage (n = 1,856)** | 509 (49.5%) | 76 (49.4%) | 433 (49.5%) | 0.975‡ | 0.1 (−8.5 to 8.7) | 376 (45.2%) | 87 (56.1%) | 289 (43.0%) | 0.003‡ | 13.1 (4.4 to 21.8) | 0.033|| |
Medical history | |||||||||||
 Cardiovascular disease (n = 920)** | 164 (32.2%) | 33 (55.9%) | 131 (29.0%) | < 0.001‡ | 26.9 (13.6 to 40.2) | 144 (35.1%) | 41 (50.6%) | 103 (31.3%) | 0.001‡ | 19.3 (7.3 to 31.3) | 0.396|| |
 Respiratory disease (n = 1,012)** | 271 (47.3%) | 41 (60.3%) | 230 (45.5%) | 0.022‡ | 14.8 (2.4 to 27.2) | 204 (46.5%) | 46 (52.9%) | 158 (44.9%) | 0.181‡ | 8.0 (−3.7 to 19.7) | 0.439|| |
 Thrombo-embolic diseases (n = 660)** | 16 (4.2%) | 3 (9.7%) | 13 (3.7%) | 0.133†| 6.0 (−4.6 to 16.6) | 8 (2.9%) | 2 (3.8%) | 6 (2.6%) | 0.645†| 1.2 (−4.4 to 6.8) | 0.557|| |
Medication use | |||||||||||
 Cardiovascular medication use | 143 (13.9%) | 33 (21.4%) | 110 (12.6%) | 0.003‡ | 8.8 (2.0 to 15.6) | 127 (15.3%) | 37 (23.9%) | 90 (13.4%) | 0.001‡ | 10.5 (3.3 to 17.7) | 0.825|| |
 Respiratory medication use | 280 (27.2%) | 40 (26.0%) | 240 (27.4%) | 0.714‡ | 1.4 (−6.1 to 8.9) | 188 (22.6%) | 36 (23.2%) | 152 (22.6%) | 0.857‡ | 0.6 (−6.8 to 8.0) | 0.702|| |
 Antithrombotic therapy | 36 (3.5%) | 8 (5.2%) | 28 (3.2%) | 0.231†| 2.0 (1.9 to 2.1) | 47 (5.7%) | 18 (11.6%) | 29 (4.3%) | < 0.001‡ | 7.3 (2.0 to 12.6) | 0.274|| |
Symptoms mentioned during the call | |||||||||||
 Ankle oedema (n = 96)** | 40 (65.6%) | 7 (70.0%) | 33 (64.7%) | 1.000†| 5.3 (−26.0 to 36.6) | 14 (40.0%) | 4 (57.1%) | 10 (35.7%) | 0.401†| 21.4 (−19.3 to 62.1) | 0.578|| |
 Anosmia (n = 100)** | 27 (60.0%) | 1 (50.0%) | 26 (60.5%) | 1.000†| 10.5 (−60.3 to 81.3) | 22 (40.0%) | 0 (0.0%) | 22 (42.3%) | 0.267†| 42.3 (28.9 to 55.7) | 0.998|| |
 Autonomic nervous system related symptoms*** (n = 1,373)** | 383 (51.3%) | 58 (54.7%) | 325 (50.7%) | 0.444‡ | 4.0 (−6.2 to 14.2) | 312 (49.8%) | 66 (56.9%) | 246 (48.2%) | 0.092‡ | 8.7 (−1.3 to 18.7) | 0.527|| |
 Coughing (n = 1,315)** | 478 (65.4%) | 77 (75.5%) | 401 (63.8%) | 0.021‡ | 11.7 (2.5 to 20.9) | 416 (71.2%) | 89 (77.4%) | 327 (69.7%) | 0.104‡ | 7.7 (−1.0 to 16.4) | 0.636|| |
 Coughing blood (n = 1,077)** | 23 (3.8%) | 5 (5.8%) | 18 (3.5%) | 0.355†| 2.3 (−2.9 to 7.5) | 25 (5.3%) | 6 (6.7%) | 19 (4.9%) | 0.598†| 1.8 (−3.8 to 7.4) | 0.806|| |
 Coughing sputum (n = 648)** | 114 (30.7%) | 15 (38.5%) | 99 (29.8%) | 0.268‡ | 8.7 (−7.3 to 24.7) | 105 (37.9%) | 22 (47.8%) | 83 (35.9%) | 0.129‡ | 11.9 (−3.8 to 27.6) | 0.825|| |
 Fever (n = 1,270)** | 163 (22.8%) | 28 (28.9%) | 135 (21.8%) | 0.123‡ | 7.1 (−2.5 to 16.7) | 184 (33.2%) | 47 (42.7%) | 137 (30.9%) | 0.018‡ | 11.8 (1.6 to 22.0) | 0.672|| |
 Malaise (n = 679)** | 290 (79.0%) | 46 (86.8%) | 244 (77.7%) | 0.148‡ | 9.1 (−1.1 to 19.3) | 246 (78.8%) | 58 (95.1%) | 188 (74.9%) | < 0.001‡ | 20.2 (12.6 to 27.8) | 0.097|| |
 Musculoskeletal pain (n = 210)** | 92 (82.1%) | 4 (66.7%) | 88 (83.0%) | 0.291†| 16.3 (−22.1 to 54.7) | 77 (78.6%) | 10 (90.9%) | 67 (77.0%) | 0.448‡ | 13.9 (−5.3 to 33.1) | 0.158|| |
 Palpitations (n = 157)** | 57 (63.3%) | 1 (20.0%) | 56 (65.9%) | 0.058†| 45.9 (9.4 to 82.4) | 42 (62.7%) | 7 (63.6%) | 35 (62.5%) | 1.000‡ | 1.1 (−30.0 to 32.2) | 0.116|| |
 Rhinitis (n = 428)** | 134 (56.8%) | 11 (45.8%) | 123 (58.0%) | 0.253‡ | 12.2 (−8.8 to 33.2) | 91 (47.4%) | 9 (39.1%) | 82 (48.5%) | 0.397†| 9.4 (−11.9 to 30.7) | 0.863|| |
 Throat complaints (n = 360)** | 132 (63.2%) | 14 (51.9%) | 118 (64.8%) | 0.192‡ | 12.9 (−7.2 to 33.0) | 91 (60.3%) | 8 (44.4%) | 83 (62.4%) | 0.199†| 18.0 (−6.4 to 42.4) | 0.769|| |
 Tingling sensations (n = 104)** | 40 (70.2%) | 3 (100.0%) | 37 (68.5%) | 0.547†| 31.5 (19.1 to 43.9) | 30 (63.8%) | 2 (100.0%) | 28 (62.2%) | 0.528†| 37.8 (23.6 to 52.0) | 1.000|| |
Chest pain characteristics | |||||||||||
 Chest pain (n = 853)** | 312 (63.7%) | 30 (50.8%) | 282 (65.4%) | 0.029‡ | 14.6 (1.1 to 28.1) | 191 (52.6%) | 29 (43.3%) | 162 (54.7%) | 0.090‡ | 11.4 (−1.7 to 24.5) | 0.712|| |
 Chest pain when breathing (n = 169)** | 84 (81.6%) | 9 (90.0%) | 75 (80.6%) | 0.684†| 9.4 (−10.9 to 29.7) | 52 (78.8%) | 7 (70.0%) | 45 (80.4%) | 0.431†| 10.4 (−19.8 to 40.6) | 0.317|| |
 Pain onset < 12 h (n = 293)** | 100 (55.6%) | 7 (50.0%) | 93 (56.0%) | 0.782†| 6.0 (−21.3 to 33.3) | 65 (57.5%) | 6 (46.2%) | 59 (59.0%) | 0.390†| 12.8 (−16.0 to 41.6) | 0.734|| |
 Pain duration > 15 min (n = 251)** | 145 (94.8%) | 10 (83.3%) | 135 (95.7%) | 0.121‡ | 12.4 (−8.9 to 33.7) | 95 (96.9%) | 11 (100.0%) | 84 (96.6%) | 1.000‡ | 3.4 (−0.4 to 7.2) | 0.999|| |
 Radiation of pain (n = 220)** | 86 (64.7%) | 8 (53.3%) | 78 (66.1%) | 0.393†| 12.8 (−13.9 to 39.5) | 42 (48.3%) | 6 (50.0%) | 36 (48.0%) | 1.000†| 2.0 (−28.5 to 32.5) | 0.460|| |
 Severe pain (score > 7 on VAS) (n = 100)** | 19 (29.7%) | 3 (60.0%) | 16 (27.1%) | 0.150†| 32.9 (−11.5 to 77.3) | 8 (22.2%) | 1 (25.0%) | 7 (21.9%) | 1.000†| 3.1 (−41.7 to 47.9) | 0.434|| |
Shortness of breath characteristics | |||||||||||
 Stridor (n = 1,147)** | 28 (4.4%) | 3 (3.7%) | 25 (4.5%) | 1.000†| 0.8 (−3.7 to 5.3) | 10 (2.0%) | 1 (1.1%) | 9 (2.2%) | 0.697†| 1.1 (−1.4 to 3.6) | 0.663|| |
 Unable to speak full sentences (n = 1,528)** | 126 (14.6%) | 49 (42.2%) | 77 (10.3%) | < 0.001‡ | 31.9 (22.6 to 41.2) | 97 (14.5%) | 41 (34.2%) | 56 (10.2%) | < 0.001‡ | 24.0 (15.1 to 32.9) | 0.309|| |
 Wheezing (n = 1,211)** | 89 (13.2%) | 19 (21.1%) | 70 (12.0%) | 0.018‡ | 9.1 (0.3 to 17.9) | 90 (16.7%) | 20 (19.6%) | 70 (16.0%) | 0.381‡ | 3.6 (−4.8 to 12.0) | 0.290|| |